BACKGROUND: High mobility group box-1 (HMGB1) protein, a critical mediator of inflammatory processes, is a novel predictor of adverse post-infarction clinical outcomes, being involved in the healing process after MI. Heart rate recovery (HRR), a marker of autonomic function defined as the fall in heart rate during the first minute after exercise, is a powerful predictor of mortality in post-infarction patients. The present study was designed to test the hypothesis that HMGB1 is associated with autonomic dysfunction in post-infarction patients. METHODS: Sixty-seven consecutive patients (mean age 59.3 years, 84% males) recovering from acute MI were included in the study protocol. All patients underwent Doppler-echocardiography, cardiopulmonary exercise and HMGB1 assay. RESULTS: HMGB1 levels were inversely correlated with peak oxygen consumption (VO(2peak)) (r=-0.449, P<0.001), with left ventricular ejection fraction (LVEF) (r=-0.360, P=0.003), and with HRR (r=-0.387, P<0.001). In a linear regression analysis adjusted for multiple confounders, we found a significant inverse association between HMGB1 levels and HRR independent of age, gender, body mass index, VO(2peak), slope of increase in ventilation over carbon dioxide output (VE/VCO(2slope)), and presence of diabetes (beta=-0.377, P=0.034). CONCLUSIONS: This study provided the first evidence for a significant association between increased HMGB1 levels and autonomic dysfunction expressed by post-exercise slower HRR in post-infarction patients. The prognostic implication of such association needs to be explored as well as whether HMGB1 could represent a valid marker for risk stratification either during the acute phase or long-term after MI. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.
BACKGROUND:High mobility group box-1 (HMGB1) protein, a critical mediator of inflammatory processes, is a novel predictor of adverse post-infarction clinical outcomes, being involved in the healing process after MI. Heart rate recovery (HRR), a marker of autonomic function defined as the fall in heart rate during the first minute after exercise, is a powerful predictor of mortality in post-infarctionpatients. The present study was designed to test the hypothesis that HMGB1 is associated with autonomic dysfunction in post-infarctionpatients. METHODS: Sixty-seven consecutive patients (mean age 59.3 years, 84% males) recovering from acute MI were included in the study protocol. All patients underwent Doppler-echocardiography, cardiopulmonary exercise and HMGB1 assay. RESULTS:HMGB1 levels were inversely correlated with peak oxygen consumption (VO(2peak)) (r=-0.449, P<0.001), with left ventricular ejection fraction (LVEF) (r=-0.360, P=0.003), and with HRR (r=-0.387, P<0.001). In a linear regression analysis adjusted for multiple confounders, we found a significant inverse association between HMGB1 levels and HRR independent of age, gender, body mass index, VO(2peak), slope of increase in ventilation over carbon dioxide output (VE/VCO(2slope)), and presence of diabetes (beta=-0.377, P=0.034). CONCLUSIONS: This study provided the first evidence for a significant association between increased HMGB1 levels and autonomic dysfunction expressed by post-exercise slower HRR in post-infarctionpatients. The prognostic implication of such association needs to be explored as well as whether HMGB1 could represent a valid marker for risk stratification either during the acute phase or long-term after MI. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.
Authors: Yiling J Cheng; Michael S Lauer; Conrad P Earnest; Timothy S Church; James B Kampert; Larry W Gibbons; Steven N Blair Journal: Diabetes Care Date: 2003-07 Impact factor: 19.112
Authors: Elliott M. Antman; Daniel T. Anbe; Paul Wayne Armstrong; Eric R. Bates; Lee A. Green; Mary Hand; Judith S. Hochman; Harlan M. Krumholz; Frederick G. Kushner; Gervasio A. Lamas; Charles J. Mullany; Joseph P. Ornato; David L. Pearle; Michael A. Sloan; Sidney C. Smith; Joseph S. Alpert; Jeffrey L. Anderson; David P. Faxon; Valentin Fuster; Raymond J. Gibbons; Gabriel Gregoratos; Jonathan L. Halperin; Loren F. Hiratzka; Sharon Ann Hunt; Alice K. Jacobs; Joseph P. Ornato Journal: J Am Coll Cardiol Date: 2004-08-04 Impact factor: 24.094
Authors: U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey Journal: J Exp Med Date: 2000-08-21 Impact factor: 14.307
Authors: H C Volz; D Laohachewin; D Schellberg; A R Wienbrandt; M Nelles; C Zugck; Z Kaya; H A Katus; M Andrassy Journal: Clin Res Cardiol Date: 2012-01-10 Impact factor: 5.460
Authors: Francesco Giallauria; Giuseppe Vitale; Mario Pacileo; Anna Di Lorenzo; Alessandro Oliviero; Francesco Passaro; Roberta Calce; Alessandro Parlato; Crescenzo Testa; Giuseppe D'Ambrosio; Giuseppe Romano; Francesco Clemenza; Silvia Sarullo; Elio Venturini; Marco Gentile; Cinzia Nugara; Gabriella Iannuzzo; Antonello D'Andrea; Carlo Vigorito; Filippo M Sarullo Journal: J Clin Med Date: 2020-06-17 Impact factor: 4.964
Authors: Francesco Giallauria; Teresa Strisciuglio; Gianluigi Cuomo; Anna Di Lorenzo; Andrea D'Angelo; Mario Volpicelli; Raffaele Izzo; Maria Virginia Manzi; Emanuele Barbato; Carmine Morisco Journal: High Blood Press Cardiovasc Prev Date: 2021-11-01